Peptide Research

The Libido Trifecta Spray Stack pairs the 10mg Kisspeptin, 10mg PT-141 and 2mg or 10mg Oxytocin Nasal Sprays. What each bottle holds, one published finding per compound and how to order in Canada.

Kisspeptin in Canada as a 10 mg vial or a ready-mixed 10 mg nasal spray, with the Libido Trifecta Spray Stack and a summary of the published human research.

Six matched peptide vial stacks, each built around one research area. What is in each stack, with every vial named by its size, and how to order peptide stacks Canada-wide.

Five matched peptide nasal spray stacks, every bottle ready-mixed in a metered nasal spray. What is in each stack, one published finding per compound, and how to order Canada-wide.

KLOW peptide is GHK-Cu, BPC-157, TB-500 and KPV in one 80 mg vial. What each does in research, vial vs nasal spray, and what a KLOW pen is.

PT-141 trials in 1,267 women raised desire and cut distress; oxytocin research on orgasm and closeness. What the female libido studies found.

PT-141, Melanotan II and oxytocin: what human studies found for erections, desire and orgasm, how fast effects appeared, and the sprays and vials we stock.

Ready-mixed oxytocin nasal spray in 2 mg and 4 mg bottles, about 70 mcg per spray, with the intranasal research and how to order Canada-wide.

Animal research on BPC-157 and thymosin beta-4 in rotator cuff, spinal cord and nerve injury, the human knee data, and the controlled trial now recruiting.

PT-141 is a synthetic peptide that activates melanocortin receptors in the brain, while oxytocin is the body’s own nine-amino-acid hormone, made in the hypothalamus and acting through a receptor of its own. PT-141’s large trials measured desire, while oxytocin’s human studies have looked at orgasm, bonding and how couples interact. Here is how they compare,…

Peptides for sleep research centre on DSIP (delta sleep-inducing peptide), the one peptide named for sleep: in a 1981 double-blind crossover study, total sleep rose 59% within about two hours of DSIP compared with placebo, and in a 1987 placebo-controlled study of 14 people with chronic insomnia, sleep efficiency reached the level of normal sleepers….

Among peptides for libido, PT-141 (bremelanotide) has the strongest research: in two 2019 phase 3 trials of 1,267 premenopausal women with low sexual desire, it raised desire scores and lowered distress about low desire compared with placebo over 24 weeks. Oxytocin, the hormone released at orgasm, has a smaller body of intranasal research on sexual…